CVE-2022-4731
Published: 25 December 2022
Summary
CVE-2022-4731 is a low-severity Cross-site Scripting (CWE-79) vulnerability in Myapnea Myapnea. Its CVSS base score is 2.4 (Low).
Operationally, ranked in the top 41.9% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2022-52033
Vulnerability details
A vulnerability, which was classified as problematic, was found in myapnea up to 29.0.x. Affected is an unknown function of the component Title Handler. The manipulation leads to cross site scripting. It is possible to launch the attack remotely. Upgrading…
more
to version 29.1.0 is able to address this issue. The name of the patch is 99934258530d761bd5d09809bfa6c14b598f8d18. It is recommended to upgrade the affected component. VDB-216750 is the identifier assigned to this vulnerability.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.